• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number US5062
Device Problems Mechanical Problem (1384); Obstruction of Flow (2423); Infusion or Flow Problem (2964)
Patient Problems Dyspnea (1816); Hypoxia (1918); Thrombus (2101); Anxiety (2328); Low Oxygen Saturation (2477); Increased Respiratory Rate (2486)
Event Date 10/04/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
It was reported that the patient was having decreasing oxygenation with patient arterial blood gas, post oxygenator arterial blood gas had decreasing pa02s.Their hemodynamics are stable, pressure gradient is stable and no signs of clot in the oxygenator.The patient is tachypneic with increased anxiety, and increasing shortness of breath.The patient was sedated and the oxygenator was changed out.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: the report of suspected thrombus and insufficient gas exchange could not be confirmed as the device is not available for investigation.A specific cause for the reported event could not conclusively be established through this evaluation.Thrombus was not confirmed.The eurosets amg pmp oxygenator, lot number unknown, was disposed of by the account and the patient was reportedly stable.The external manufacturer confirmed that all tests from the production process were compliant with the technical specifications and confirmed that they apply the 100% production process test to all devices.The eurosets amg pmp instructions for use (ifu) is currently available.Under the section titled, ¿intended use¿, the ifu states that the ¿a.M.G.Module pmp no t.P.Sterile is intended for use in adult surgical procedures requiring extracorporeal gas exchange support and blood temperature control for periods of up to 6 hours¿ and also that the device ¿is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.Contact with blood for a longer period of time is unadvisable.¿ under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary and also wants that the extracorporeal circulation has to be carefully and continuously checked.Under the list of precautions, the ifu cautions that a strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures.The benefit of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.Adequate heparinization must be maintained before and during bypass.The "priming and recirculation procedure" section warns to check the correct dosage of anticoagulant in the system before starting the bypass.The "bypass start" section states to check that anticoagulation level (act) is appropriate before starting the procedure.This section also contains a subsection on blood gas monitoring and explains how to adjust the relevant parameters based on the patient¿s blood gas values.The "during bypass" warns that the act (activated coagulation time) must always be longer than or equal to 480 seconds in order to ensure adequate anticoagulation of the extracorporeal circuit.Under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
EUROSETS S.R.L.
strada statale 12, n°143
medolla, modena 41036
IT  41036
MDR Report Key10741900
MDR Text Key213259653
Report Number3003752502-2020-04151
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K141492
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUS5062
Device Catalogue NumberUS5062
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age41 YR
Patient Weight89
-
-